• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Refractory pediatric ulcerative colitis responding to high dose tofacitinib.

作者信息

Miyata Eri, Arai Katsuhiro, Takeuchi Ichiro, Shimizu Hirotaka, Shimizu Toshiaki

机构信息

Division of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Setagaya-ku, Japan.

Department of Pediatrics, Juntendo University Faculty of Medicine, Bunkyo-ku, Japan.

出版信息

Pediatr Int. 2023 Jan-Dec;65(1):e15551. doi: 10.1111/ped.15551.

DOI:10.1111/ped.15551
PMID:37350552
Abstract
摘要

相似文献

1
Refractory pediatric ulcerative colitis responding to high dose tofacitinib.难治性小儿溃疡性结肠炎对高剂量托法替布有反应。
Pediatr Int. 2023 Jan-Dec;65(1):e15551. doi: 10.1111/ped.15551.
2
Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis.英夫利昔单抗补救治疗后序贯使用高剂量托法替布治疗急性重度溃疡性结肠炎。
J Crohns Colitis. 2022 Jan 28;16(1):166-168. doi: 10.1093/ecco-jcc/jjab109.
3
Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.环孢素和托法替尼联合治疗在一例严重激素抵抗溃疡性结肠炎患者中的成功应用。
Inflamm Bowel Dis. 2021 Nov 15;27(12):e157-e158. doi: 10.1093/ibd/izab181.
4
High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.高剂量挽救性托法替布可预防抗TNF治疗无效的急性重度溃疡性结肠炎患者住院行结肠切除术。
Inflamm Bowel Dis. 2021 Apr 15;27(5):e59-e60. doi: 10.1093/ibd/izaa357.
5
Efficacy of tofacitinib treatment in ulcerative colitis.托法替布治疗溃疡性结肠炎的疗效。
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14.
6
Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.托法替布作为第六线药物在难治性溃疡性结肠炎中诱导长期临床、内镜及组织学缓解
Inflamm Bowel Dis. 2021 Feb 16;27(3):e35-e36. doi: 10.1093/ibd/izaa296.
7
Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.托法替尼治疗急性重度溃疡性结肠炎的补救治疗:真实世界经验。
J Crohns Colitis. 2020 Jul 30;14(7):1026-1028. doi: 10.1093/ecco-jcc/jjaa018.
8
A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.一例结节性红斑合并溃疡性结肠炎患者经托法替布治疗后病情缓解。
Dermatol Ther. 2022 Dec;35(12):e15963. doi: 10.1111/dth.15963. Epub 2022 Nov 10.
9
Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine?
Aliment Pharmacol Ther. 2022 Jul;56(2):347-348. doi: 10.1111/apt.17038.
10
A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.一例大动脉炎合并难治性溃疡性结肠炎患者经托法替布治疗成功
Rheumatology (Oxford). 2020 Jul 1;59(7):1773-1775. doi: 10.1093/rheumatology/kez580.

引用本文的文献

1
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice.托法替布在溃疡性结肠炎中的应用:日常临床实践专家共识
Indian J Gastroenterol. 2024 Feb;43(1):22-35. doi: 10.1007/s12664-023-01507-9. Epub 2024 Feb 12.